LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019: Results from the Brazilian multicenter cohort study.

    Requião-Moura, Lúcio R / Sandes-Freitas, Tainá Veras de / Viana, Laila Almeida / Cristelli, Marina Pontello / Andrade, Luis Gustavo Modelli de / Garcia, Valter Duro / Oliveira, Claudia Maria Costa de / Esmeraldo, Ronaldo de Matos / Abbud Filho, Mario / Pacheco-Silva, Alvaro / Sousa, Katia Cronemberger / Vicari, Alessandra Rosa / Costa, Kellen Micheline Alves Henrique / Simão, Denise Rodrigues / Sousa, Marcos Vinicius de / Campos, Juliana Bastos / Almeida, Ricardo Augusto Monteiro de Barros / Deboni, Luciane Mônica / Neto, Miguel Moysés /
    Zanocco, Juliana Aparecida / Tedesco-Silva, Helio / Medina-Pestana, José

    PloS one

    2021  Volume 16, Issue 7, Page(s) e0254822

    Abstract: Background: Kidney transplant (KT) recipients are considered a high-risk group for unfavorable ... and outcomes of COVID-19 among KT recipients.: Methods: This multicenter cohort study enrolled 1 ... 680 KT recipients diagnosed with COVID-19 between March and November 2020, from 35 Brazilian centers ...

    Abstract Background: Kidney transplant (KT) recipients are considered a high-risk group for unfavorable outcomes in the course of coronavirus disease 2019 (COVID-19).
    Aim: To describe the clinical aspects and outcomes of COVID-19 among KT recipients.
    Methods: This multicenter cohort study enrolled 1,680 KT recipients diagnosed with COVID-19 between March and November 2020, from 35 Brazilian centers. The main outcome was the 90-day cumulative incidence of death, for the entire cohort and according to acute kidney injury (AKI) and renal replacement therapy (RRT) requirement. Fatality rates were analyzed according to hospitalization, intensive care unit (ICU) admission, and mechanical ventilation (MV) requirement. Multivariable analysis was performed by logistic regression for the probability of hospitalization and death.
    Results: The median age of the recipients was 51.3 years, 60.4% were men and 11.4% were Afro-Brazilian. Comorbidities were reported in 1,489 (88.6%), and the interval between transplantation and infection was 5.9 years. The most frequent symptoms were cough (54%), myalgia (40%), dyspnea (37%), and diarrhea (31%), whereas the clinical signs were fever (61%) and hypoxemia (13%). Hospitalization was required in 65.1%, and immunosuppressive drugs adjustments were made in 74.4% of in-hospital patients. ICU admission was required in 34.6% and MV in 24.9%. In the multivariable modeling, the variables related with the probability of hospitalization were age, hypertension, previous cardiovascular disease, recent use of high dose of steroid, and fever, dyspnea, diarrhea, and nausea or vomiting as COVID-19 symptoms. On the other hand, the variables that reduced the probability of hospitalization were time of COVID-19 symptoms, and nasal congestion, headache, arthralgia and anosmia as COVID-19 symptoms. The overall 90-day cumulative incidence of death was 21.0%. The fatality rates were 31.6%, 58.2%, and 75.5% in those who were hospitalized, admitted to the ICU, and required MV, respectively. At the time of infection, 23.2% had AKI and 23.4% required RRT in the follow-up. The cumulative incidence of death was significantly higher among recipients with AKI (36.0% vs. 19.1%, P < 0.0001) and in those who required RRT (70.8% vs. 10.1%, P < 0.0001). The variables related with the probability of death within 90 days after COVID-19 were age, time after transplantation, presence of hypertension, previous cardiovascular disease, use of tacrolimus and mycophenolate, recent use of high dose of steroids, and dyspnea as COVID-19 symptom. On the other hand, the variables that reduced the risk of death were time of symptoms, and headache and anosmia as COVID-19 symptoms.
    Conclusion: The patients diagnosed with COVID-19 were long-term KT recipients and most of them had some comorbidities. One in every five patients died, and the rate of death was significantly higher in those with AKI, mainly when RRT was required.
    MeSH term(s) Acute Kidney Injury ; Adult ; Aged ; Brazil/epidemiology ; COVID-19/complications ; COVID-19/mortality ; Cohort Studies ; Comorbidity ; Female ; Hospital Mortality ; Humans ; Intensive Care Units ; Kidney Transplantation/adverse effects ; Kidney Transplantation/methods ; Kidney Transplantation/mortality ; Male ; Middle Aged ; Renal Replacement Therapy ; Respiration, Artificial/adverse effects ; Retrospective Studies ; Risk Factors ; SARS-CoV-2/isolation & purification ; Transplant Recipients/statistics & numerical data
    Language English
    Publishing date 2021-07-28
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0254822
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019

    Lúcio R Requião-Moura / Tainá Veras de Sandes-Freitas / Laila Almeida Viana / Marina Pontello Cristelli / Luis Gustavo Modelli de Andrade / Valter Duro Garcia / Claudia Maria Costa de Oliveira / Ronaldo de Matos Esmeraldo / Mario Abbud Filho / Alvaro Pacheco-Silva / Katia Cronemberger Sousa / Alessandra Rosa Vicari / Kellen Micheline Alves Henrique Costa / Denise Rodrigues Simão / Marcos Vinicius de Sousa / Juliana Bastos Campos / Ricardo Augusto Monteiro de Barros Almeida / Luciane Mônica Deboni / Miguel Moysés Neto /
    Juliana Aparecida Zanocco / Helio Tedesco-Silva / José Medina-Pestana / COVID-19-KT Brazil

    PLoS ONE, Vol 16, Iss 7, p e

    Results from the Brazilian multicenter cohort study.

    2021  Volume 0254822

    Abstract: Background Kidney transplant (KT) recipients are considered a high-risk group for unfavorable ... outcomes of COVID-19 among KT recipients. Methods This multicenter cohort study enrolled 1,680 KT ... recipients diagnosed with COVID-19 between March and November 2020, from 35 Brazilian centers. The main ...

    Abstract Background Kidney transplant (KT) recipients are considered a high-risk group for unfavorable outcomes in the course of coronavirus disease 2019 (COVID-19). Aim To describe the clinical aspects and outcomes of COVID-19 among KT recipients. Methods This multicenter cohort study enrolled 1,680 KT recipients diagnosed with COVID-19 between March and November 2020, from 35 Brazilian centers. The main outcome was the 90-day cumulative incidence of death, for the entire cohort and according to acute kidney injury (AKI) and renal replacement therapy (RRT) requirement. Fatality rates were analyzed according to hospitalization, intensive care unit (ICU) admission, and mechanical ventilation (MV) requirement. Multivariable analysis was performed by logistic regression for the probability of hospitalization and death. Results The median age of the recipients was 51.3 years, 60.4% were men and 11.4% were Afro-Brazilian. Comorbidities were reported in 1,489 (88.6%), and the interval between transplantation and infection was 5.9 years. The most frequent symptoms were cough (54%), myalgia (40%), dyspnea (37%), and diarrhea (31%), whereas the clinical signs were fever (61%) and hypoxemia (13%). Hospitalization was required in 65.1%, and immunosuppressive drugs adjustments were made in 74.4% of in-hospital patients. ICU admission was required in 34.6% and MV in 24.9%. In the multivariable modeling, the variables related with the probability of hospitalization were age, hypertension, previous cardiovascular disease, recent use of high dose of steroid, and fever, dyspnea, diarrhea, and nausea or vomiting as COVID-19 symptoms. On the other hand, the variables that reduced the probability of hospitalization were time of COVID-19 symptoms, and nasal congestion, headache, arthralgia and anosmia as COVID-19 symptoms. The overall 90-day cumulative incidence of death was 21.0%. The fatality rates were 31.6%, 58.2%, and 75.5% in those who were hospitalized, admitted to the ICU, and required MV, respectively. At the time of infection, 23.2% had AKI and 23.4% required RRT in the follow-up. The cumulative incidence of death was significantly higher among recipients with AKI (36.0% vs. 19.1%, P < 0.0001) and in those who required RRT (70.8% vs. 10.1%, P < 0.0001). The variables related with the probability of death within 90 days after COVID-19 were age, time after transplantation, presence of hypertension, previous cardiovascular disease, use of tacrolimus and mycophenolate, recent use of high dose of steroids, and dyspnea as COVID-19 symptom. On the other hand, the variables that reduced the risk of death were time of symptoms, and headache and anosmia as COVID-19 symptoms. Conclusion The patients diagnosed with COVID-19 were long-term KT recipients and most of them had some comorbidities. One in every five patients died, and the rate of death was significantly higher in those with AKI, mainly when RRT was required.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top